The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multi-centre, stratified, open, randomized, comparator-controlled, parallel group phase II trial comparing adjuvant treatment with 177Lu-DOTATATE to standard of care in patients after resection of neuroendocrine liver metastases (NELMAS).
 
Andreja Frilling
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis
 
Richard Baum
Employment - Curanosticum Wiesbaden-Frankfurt MVZ
Stock and Other Ownership Interests - ITM Isotope Technologies Munich; Telix Pharmaceuticals
Honoraria - Monrol; Novartis
Consulting or Advisory Role - 3B Pharmaceuticals; Full Life Technologies; Isotopen Technologien
Patents, Royalties, Other Intellectual Property - Verfahren zur Prävention von Strahlenschäden in humanen Drüsen
(OPTIONAL) Uncompensated Relationships - President ICPO Academy, Chairman of the Scientific Board (Foundation)
 
Kirill Veselkov
No Relationships to Disclose
 
Elena Ferrer Martinez Del Peral
No Relationships to Disclose
 
Maria Martinez
No Relationships to Disclose
 
Marcos Lovelle
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Jiwen Wu
Employment - Geron (I); Novartis
Stock and Other Ownership Interests - Geron (I); Novartis
 
Son-Mi Park
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Patents, Royalties, Other Intellectual Property - Bayer HealthCare Pharmacuticals
 
Ashley Clift
No Relationships to Disclose
 
Amy Eccles
No Relationships to Disclose
 
James Hubber
No Relationships to Disclose
 
Harpreet Wasan
Honoraria - Array BioPharma; Celgene; ERYTECH Pharma; Incyte; Merck KGaA; Roche/Genentech; Servier; Sirtex Medical; Zymeworks
Consulting or Advisory Role - Bayer; ERYTECH Pharma; Incyte; Pfizer; Pierre Fabre; Roche Pharma AG; Shire; Sirtex medical
Speakers' Bureau - Celgene; Incyte; Merck KGaA; SERVIER; Sirtex Medical
Research Funding - Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Sirtex Medical (Inst)
Expert Testimony - Oncosil
 
Irvin Modlin
No Relationships to Disclose